Lockheed Martin Investment Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-16,500
Closed -$3.38M 141
2017
Q3
$3.38M Buy
16,500
+6,700
+68% +$1.56M 0.18% 56
2017
Q2
$2.38M Sell
9,800
-4,600
-32% -$1.08M 0.13% 77
2017
Q1
$3.44M Sell
14,400
-2,500
-15% -$582K 0.2% 68
2016
Q4
$3.55M Buy
16,900
+6,900
+69% +$1.43M 0.3% 46
2016
Q3
$2.3M Sell
10,000
-10,000
-50% -$2.44M 0.2% 68
2016
Q2
$4.62M Sell
20,000
-3,600
-15% -$830K 0.46% 36
2016
Q1
$6.33M Buy
23,600
+3,500
+17% +$1M 0.61% 25
2015
Q4
$6.28M Sell
20,100
-3,600
-15% -$1.07M 0.59% 29
2015
Q3
$6.44M Buy
23,700
+8,334
+54% +$2.56M 0.72% 22
2015
Q2
$4.66M Buy
+15,366
New +$4.58M 0.23% 48

Other funds holding AGN

Lockheed Martin Investment Management's AGN Position: Q4 2017 in Review

Lockheed Martin Investment Management sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 16,500 shares — an estimated $3.38M sold.

Lockheed Martin Investment Management first reported a position in AGN in Q2 2015 and held it in 10 quarters. The position peaked at $6.44M in Q3 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Lockheed Martin Investment Management reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Lockheed Martin Investment Management sold 16,500 Allergan plc shares in Q4 2017, an estimated $3.38M.
  • Lockheed Martin Investment Management first reported a position in Allergan plc in Q2 2015 and held it in 10 quarters.
  • Lockheed Martin Investment Management's Allergan plc position peaked at $6.44M in Q3 2015.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Lockheed Martin Investment Management's 13F filing for Q4 2017, filed 18 Jan 2018.